Fulgent Genetics Stock Investor Sentiment
| FLGT Stock | USD 20.64 0.08 0.39% |
Slightly above 53% of Fulgent Genetics' private investors are presently thinking to get in. The analysis of overall sentiment of trading Fulgent Genetics stock suggests that some investors are interested at this time. Fulgent Genetics' investor sentiment overview provides quick insight into current market opportunities from investing in Fulgent Genetics. The current market sentiment, together with Fulgent Genetics' historical and current headlines, can help investors time the market. In addition, many technical investors use Fulgent Genetics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Fulgent Genetics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Fulgent daily returns and investor perception about the current price of Fulgent Genetics as well as its diversification or hedging effects on your existing portfolios.
Fulgent |
Fulgent Genetics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Fulgent Genetics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Fulgent Genetics that are available to investors today. That information is available publicly through Fulgent media outlets and privately through word of mouth or via Fulgent internal channels. However, regardless of the origin, that massive amount of Fulgent data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Fulgent Genetics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Fulgent Genetics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Fulgent Genetics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Fulgent Genetics alpha.
Fulgent Genetics Performance against NYSE Composite
Price Growth (%) |
| Timeline |
1 | Payment of 4683 shares by Jian Xie of Fulgent Genetics subject to Rule 16b-3 | 01/30/2024 |
2 | Payment of 6719 shares by Jian Xie of Fulgent Genetics subject to Rule 16b-3 | 02/06/2024 |
3 | ROSEN, A LEADING LAW FIRM, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important ... - The Globe and Mail | 02/15/2024 |
4 | Disposition of 8667 shares by Ming Hsieh of Fulgent Genetics at 24.06 subject to Rule 16b-3 | 02/23/2024 |
5 | Acquisition by Jian Xie of 27 shares of Fulgent Genetics subject to Rule 16b-3 | 02/26/2024 |
6 | Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results | 02/28/2024 |
7 | Fulgent Genetics, Inc. Q4 2023 Earnings Call Transcript | 02/29/2024 |
8 | Fulgent Genetics Full Year 2023 Earnings Revenues Beat Expectations, EPS Lags | 03/01/2024 |
9 | Disposition of 1075 shares by Jian Xie of Fulgent Genetics at 23.24 subject to Rule 16b-3 | 03/05/2024 |
10 | Fulgent Genetics PT Lowered to 25.00 at Piper Sandler - MarketBeat | 03/06/2024 |
11 | Fulgent Genetics Reaches New 12-Month Low at 22.25 - MarketBeat | 03/14/2024 |
12 | Are Medical Stocks Lagging Fulgent Genetics This Year - Yahoo Movies UK | 03/20/2024 |
13 | Disposition of 865 shares by Paul Kim of Fulgent Genetics at 29.33 subject to Rule 16b-3 | 03/27/2024 |
14 | Fulgent Genetics Reaches New 1-Year Low at 21.20 - MarketBeat | 04/01/2024 |
15 | Fulgent Genetics shareholders have earned a 26 percent CAGR over the last five years | 04/11/2024 |
16 | Acquisition by Ming Hsieh of 750000 shares of Fulgent Genetics subject to Rule 16b-3 | 04/19/2024 |
Check out Fulgent Genetics Hype Analysis, Fulgent Genetics Correlation and Fulgent Genetics Performance. For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.Note that the Fulgent Genetics information on this page should be used as a complementary analysis to other Fulgent Genetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Fulgent Stock analysis
When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Fulgent Genetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fulgent Genetics. If investors know Fulgent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fulgent Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.99) | Earnings Share (5.63) | Revenue Per Share 9.71 | Quarterly Revenue Growth 0.041 | Return On Assets (0.03) |
The market value of Fulgent Genetics is measured differently than its book value, which is the value of Fulgent that is recorded on the company's balance sheet. Investors also form their own opinion of Fulgent Genetics' value that differs from its market value or its book value, called intrinsic value, which is Fulgent Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fulgent Genetics' market value can be influenced by many factors that don't directly affect Fulgent Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fulgent Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fulgent Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fulgent Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.